Fei (FEIC) 10-Q 30 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 28, 2014	Oct. 28, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'FEI CO	'
Entity Central Index Key	'0000914329	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	28-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	41,549,522

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$272,441	$384,170
Short-term investments in marketable securities	92,589	108,191
Short-term restricted cash	11,988	18,798
Receivables, net of allowances for doubtful accounts of $2,854 and $2,969	219,203	194,418
Inventories	190,394	181,725
Deferred tax assets	9,890	15,114
Other current assets	42,648	28,324
Total current assets	839,153	930,740
Non-current investments in marketable securities	77,005	47,278
Long-term restricted cash	38,953	32,718
Property, plant and equipment, net of accumulated depreciation of $137,808 and $125,405	166,520	157,829
Intangible assets, net of accumulated amortization of $27,231 and $19,385	59,371	47,197
Goodwill	177,820	136,152
Deferred tax assets	9,156	1,751
Non-current inventories	53,845	62,104
Other assets, net	17,693	10,315
Total Assets	1,439,516	1,426,084
Current Liabilities:	'	'
Accounts payable	79,584	73,247
Accrued payroll liabilities	36,842	45,146
Accrued warranty reserves	12,128	12,705
Short-term deferred revenue	92,386	91,563
Income taxes payable	12,435	4,579
Accrued restructuring, reorganization, relocation and severance	6,462	50
Other current liabilities	55,907	46,324
Total current liabilities	295,744	273,614
Long-term deferred revenue	33,255	30,744
Deferred tax liabilities	10,405	8,931
Other liabilities	33,883	35,227
Commitments and contingencies	'	'
Shareholders’ Equity:	'	'
Preferred stock - 500 shares authorized; none issued and outstanding	0	0
Common stock - 70,000 shares authorized; 41,844 and 42,136 shares issued and outstanding, no par value	623,092	637,482
Retained earnings	438,564	392,958
Accumulated other comprehensive income	4,573	47,128
Total Shareholders’ Equity	1,066,229	1,077,568
Total Liabilities and Shareholders’ Equity	$1,439,516	$1,426,084

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Assets	'	'
Allowance for doubtful accounts	$2,854	$2,969
Accumulated depreciation	137,808	125,405
Accumulated amortization	$27,231	$19,385
Shareholders’ Equity:	'	'
Preferred stock, shares authorized	500	500
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	70,000	70,000
Common stock, shares issued	41,844	42,136
Common stock, shares outstanding	41,844	42,136
Common stock, no par value	$0	$0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Net sales:	'	'	'	'
Products	$169,131	$162,452	$517,459	$502,284
Service	58,625	56,044	173,517	159,879
Total net sales	227,756	218,496	690,976	662,163
Cost of sales:	'	'	'	'
Products	83,653	79,894	262,327	247,757
Service	35,522	33,857	103,893	100,213
Total cost of sales	119,175	113,751	366,220	347,970
Gross profit	108,581	104,745	324,756	314,193
Operating expenses:	'	'	'	'
Research and development	25,312	25,397	77,178	75,619
Selling, general and administrative	49,463	45,346	148,513	131,509
Restructuring, reorganization, relocation and severance	7,699	0	11,259	1,090
Total operating expenses	82,474	70,743	236,950	208,218
Operating income	26,107	34,002	87,806	105,975
Other expense:	'	'	'	'
Interest income	226	175	599	428
Interest expense	-155	-231	-427	-1,716
Other, net	-902	-605	-2,079	-2,330
Total other expense, net	-831	-661	-1,907	-3,618
Income before income taxes	25,276	33,341	85,899	102,357
Income tax expense	3,629	4,735	14,228	16,957
Net income	$21,647	$28,606	$71,671	$85,400
Basic net income per share	$0.52	$0.69	$1.70	$2.14
Diluted net income per share	$0.51	$0.67	$1.68	$2.04
Cash dividends declared per share	$0.25	$0.12	$0.62	$0.32
Shares used in per share calculations:	'	'	'	'
Basic (in shares)	41,891	41,750	42,053	39,928
Diluted (in shares)	42,465	42,455	42,624	42,300

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income	$21,647	$28,606	$71,671	$85,400
Other comprehensive (loss) income, net of taxes:	'	'	'	'
Change in cumulative translation adjustment	-37,778	17,126	-39,534	7,773
Change in unrealized gain on available-for-sale securities	-52	24	-12	21
Change in minimum pension liability	45	-70	78	-141
Changes due to cash flow hedging instruments:	'	'	'	'
Net (loss) gain on hedge instruments	-5,475	1,292	-7,250	-563
Reclassification to net income of previously deferred losses related to hedge derivatives instruments	2,534	-120	4,163	506
Comprehensive (loss) income	($19,079)	$46,858	$29,116	$92,996

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Cash flows from operating activities:	'	'
Net income	$71,671	$85,400
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	22,379	17,442
Amortization	10,478	7,868
Stock-based compensation	17,456	13,316
Asset impairments, write-offs of intangible assets and other	322	17
Income taxes (receivable) payable, net	-4,010	11,448
Deferred income taxes	-2,275	-4,442
Decrease (increase), net of acquisitions, in:	'	'
Receivables	-27,840	-4,073
Inventories	-26,772	-8,544
Other assets	-4,882	990
Increase (decrease), net of acquisitions, in:	'	'
Accounts payable	9,655	14,865
Accrued payroll liabilities	-9,872	-5,017
Accrued warranty reserves	-288	327
Deferred revenue	9,120	13,698
Accrued restructuring, reorganization, relocation and severance	6,709	-2,309
Other liabilities	747	-742
Net cash provided by operating activities	72,598	140,244
Cash flows from investing activities:	'	'
Increase in restricted cash	-3,034	-8,176
Acquisition of property, plant and equipment	-35,429	-47,152
Payments for acquisitions, net of cash acquired	-65,049	-2,694
Purchase of investments in marketable securities	-189,621	-132,965
Redemption of investments in marketable securities	175,424	119,349
Other	-736	-2,366
Net cash used in investing activities	-118,445	-74,004
Cash flows from financing activities:	'	'
Redemption of 2.875% convertible notes	0	-73
Dividends paid on common stock	-20,619	-11,173
Withholding taxes paid on issuance of vested restricted stock units	-1,784	-954
Proceeds from exercise of stock options and employee stock purchases	10,628	9,081
Excess tax benefit for share based payment arrangements	2,096	1,169
Repurchases of common stock	-40,315	0
Net cash used in financing activities	-49,994	-1,950
Effect of exchange rate changes	-15,888	4,910
(Decrease) increase in cash and cash equivalents	-111,729	69,200
Cash and cash equivalents:	'	'
Beginning of period	384,170	266,302
End of period	272,441	335,502
Supplemental Cash Flow Information:	'	'
Cash paid for income taxes, net	14,458	7,505
Cash paid for interest	261	1,627
Increase in fixed assets related to transfers with inventories	4,345	8,285
Dividends declared but not paid	10,461	5,011
Conversion of 2.875% convertible notes	0	88,937
Accrued purchases of plant and equipment	$986	$6,434
Convertible Subordinated Debt [Member]	'	'
Supplemental Cash Flow Information:	'	'
Convertible notes, stated interest rate	0.00%	2.88%

Organization_and_Basis_of_Pres

Organization and Basis of Presentation	9 Months Ended
	Sep. 28, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Basis of Presentation	'
	ORGANIZATION AND BASIS OF PRESENTATION
	Nature of Business
	We are a leading supplier of scientific instruments and related services for nanoscale applications and solutions for industry and science. We report our revenue based on a group structure organization, which we categorize as the Industry Group and the Science Group.
	Our products include transmission electron microscopes (“TEMs”); scanning electron microscopes (“SEMs”); DualBeamTM systems which combine a SEM and a focused ion beam system (“FIB”) on a single platform; stand-alone FIBs; high-performance optical microscopes, three-dimensional modeling software, and service and components to support the products. TEMs provide the highest resolution images of samples and their internal structure, down to the atomic level. SEMs provide detailed images of the surface and shape of samples. Optical microscopes provide a wider field of view than SEMs and TEMs. DualBeams and FIBs image, manipulate, mill and deposit material for a variety of purposes, including preparation of samples for TEMs. Substantially all of these product categories are sold into all of our markets. Individual models of our products are increasingly designed to provide specific solutions and applications in each of our markets.
	Our DualBeam systems include models that have wafer handling capability and are purchased by semiconductor equipment manufacturers (“wafer-level DualBeam systems”) and models that have small stages and are sold to customers in several markets (“small-stage DualBeam systems”).
	Our significant research and development and manufacturing operations are located in Hillsboro, Oregon; Eindhoven, The Netherlands; and Brno, Czech Republic; and our software development is managed principally from Bordeaux, France. Our sales and service operations are conducted in the United States (U.S.) and approximately 50 other countries around the world. We also sell our products through independent agents, distributors and representatives in additional countries.
	Basis of Presentation
	The consolidated financial statements include the accounts of FEI Company and our wholly-owned subsidiaries (collectively, “FEI”). All significant intercompany balances and transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements and condensed footnotes have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments considered necessary for fair presentation have been included. The results of operations for the thirteen and thirty-nine week periods ended September 28, 2014 are not necessarily indicative of the results to be expected for the full year. For further information, refer to the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013, which was filed with the Securities and Exchange Commission (“SEC”) on February 21, 2014.
	Use of Estimates in Financial Reporting
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.
	Significant accounting policies and estimates underlying the accompanying consolidated financial statements include:
	•	the timing of revenue recognition;
	•	valuations of excess and obsolete inventory;
	•	the lives and recoverability of equipment and other long-lived assets such as goodwill;
	•	the valuations of intangible assets;
	•	restructuring, reorganization, relocation and severance costs;
	•	tax valuation allowances and unrecognized tax benefits;
	•	stock-based compensation; and
	•	accounting for derivatives.
	It is reasonably possible that management's estimates may change in the future.
	Reclassifications
	Certain reclassifications to prior year consolidated financial statements have been made to conform to current period presentation. These reclassifications had no effect on our Consolidated Statements of Operations.

Earnings_Per_Share

Earnings Per Share	9 Months Ended
	Sep. 28, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	EARNINGS PER SHARE
	Following is a reconciliation of basic earnings per share (“EPS”) and diluted EPS (in thousands, except per share amounts):
		Thirteen Weeks Ended								Thirteen Weeks Ended
		September 28, 2014								September 29, 2013
		Net			Shares		Per Share			Net		Shares	Per Share
		Income					Amount			Income			Amount
	Basic EPS	$	21,647		41,891		$	0.52		$	28,606	41,750	$	0.69
	Dilutive effect of 2.875% convertible debt	—			—		—			—		—	—
	Dilutive effect of stock options, restricted stock units, and shares issuable to Philips	—			574		(0.01		)	—		705	(0.02		)
	Diluted EPS	$	21,647		42,465		$	0.51		$	28,606	42,455	$	0.67
		Thirty-Nine Weeks Ended								Thirty-Nine Weeks Ended
		September 28, 2014								September 29, 2013
		Net			Shares		Per Share			Net		Shares	Per Share
		Income					Amount			Income			Amount
	Basic EPS	$	71,671		42,053		$	1.7		$	85,400	39,928	$	2.14
	Dilutive effect of 2.875% convertible debt	—			—		—			780		1,727	(0.07		)
	Dilutive effect of stock options, restricted stock units, and shares issuable to Philips	—			571		(0.02		)	—		645	(0.03		)
	Diluted EPS	$	71,671		42,624		$	1.68		$	86,180	42,300	$	2.04
	The following table sets forth the schedule of anti-dilutive securities excluded from the computation of diluted EPS (number of shares, in thousands):
		Thirteen Weeks Ended				Thirty-Nine Weeks Ended
		September 28,		September 29,		September 28,			September 29,
		2014		2013		2014			2013
	Stock options	361		31		246			220
	Restricted stock units	10		1		8			1

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 28, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation	'
	STOCK-BASED COMPENSATION
	Employee Share Purchase Plan
	At our 2014 Annual Meeting of Shareholders, which was held on May 8, 2014, our shareholders approved an amendment to our Employee Share Purchase Plan to increase the number of shares of our common stock reserved for issuance under the plan from 3,950,000 to 4,200,000.
	1995 Stock Incentive Plan
	Also at our 2014 Annual Meeting of Shareholders, our shareholders approved an amendment to our 1995 Stock Incentive Plan (the “1995 Plan”) to increase the number of shares of our common stock reserved for issuance under the plan from 11,000,000 to 11,250,000.
	The following table sets forth certain information regarding the 1995 Plan:
		September 28,
		2014
	Shares available for grant	1,876,336
	Shares of common stock reserved for issuance [pursuant to outstanding exercisable securities]	3,578,885
	The following table sets forth certain information regarding all options outstanding and exercisable:
		September 28, 2014
		Options		Options
		Outstanding		Exercisable
	Number	866,618		173,889
	Weighted average exercise price	$	60.2	$	38.69
	Aggregate intrinsic value	$ 17.9 million		$ 6.9 million
	Weighted average remaining contractual term	5.1 years		3.6 years
	The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
		September 28, 2014
		RSUs Nonvested		RSUs Expected
				to Vest
	Number	835,933		750,036
	Weighted average grant date per share fair value	$	63.75	$	62.68
	Aggregate intrinsic value	$ 65.3 million		$ 58.6 million
	Weighted average remaining term to vest	1.3 years		1.2 years
	As of September 28, 2014, unrecognized stock-based compensation related to outstanding, but unvested stock options and RSUs was $49.9 million, which will be recognized over the weighted average remaining vesting period of 1.9 years.
	Stock-Based Compensation Expense
	Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands):
		Thirteen Weeks Ended				Thirty-Nine Weeks Ended
		September 28,		September 29,		September 28,		September 29,
		2014		2013		2014		2013
	Cost of sales	$	912	$	571	$	2,495	$	1,782
	Research and development	762		511		2,092		1,587
	Selling, general and administrative	4,820		3,522		12,869		9,947
	Total stock-based compensation	$	6,494	$	4,604	$	17,456	$	13,316

Credit_Facilities_and_Restrict

Credit Facilities and Restricted Cash	9 Months Ended
	Sep. 28, 2014
Credit Facilities And Restricted Cash	'
Credit Facilities and Restricted Cash	'
	CREDIT FACILITIES AND RESTRICTED CASH
	Multibank Credit Agreement
	We have a multibank credit agreement (the “Credit Agreement”), which provides for a $100.0 million secured revolving credit facility, including a $50.0 million subfacility for the issuance of letters of credit. The credit agreement expires April 1, 2016. We may, upon notice to JPMorgan Chase Bank, N.A., the Administrative Agent (the “Agent”), request to increase the revolving loan commitments by an aggregate amount of up to $50.0 million with new or additional commitments subject only to the consent of the lender(s) providing the new or additional commitments, for a total secured credit facility of up to $150.0 million. As of September 28, 2014, there were no revolving loans or letters of credit outstanding under the Credit Agreement, we were in compliance with all covenants and we were not in default under the Credit Agreement.
	On July 3, 2014, we entered into the Third Amendment to Credit Agreement (the “Third Amendment”) with the Agent, various lenders (the “Lenders”) and certain other parties. Among other things, the Third Amendment amended the Credit Agreement to increase the permitted amount of restricted payments, subject to certain conditions and certain technical amendments.
	Restricted Cash
	As part of our contracts with certain customers, we are required to provide letters of credit or bank guarantees which these customers can draw against in the event we do not perform in accordance with our contractual obligations. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets.
	The following table sets forth information related to guarantees and letters of credit (in thousands):
		September 28,
		2014
	Guarantees and letters of credit outstanding	$	51,817
	Amount secured by restricted cash deposits:
	Current	$	11,988
	Long-term	38,953
	Total secured by restricted cash	$	50,941

Inventories

Inventories	9 Months Ended
	Sep. 28, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	INVENTORIES
	Inventories are stated at the lower of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as a long-term asset. Management has established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory.
	Inventories consisted of the following (in thousands):
		September 28,		December 31,
		2014		2013
	Raw materials and assembled parts	$	60,219	$	61,235
	Service inventories, estimated current requirements	13,208		15,197
	Work-in-process	83,475		75,883
	Finished goods	33,492		29,410
	Total current inventories	$	190,394	$	181,725
	Non-current inventories	$	53,845	$	62,104

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 28, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Other Intangible Assets	'
	GOODWILL AND OTHER INTANGIBLE ASSETS
	Goodwill
	The roll-forward of activity related to our goodwill was as follows (in thousands):
		Thirty-Nine Weeks Ended
		September 28,			September 29,
		2014			2013
	Balance, beginning of period	$	136,152		$	131,320
	Goodwill additions	46,880			3,545
	Goodwill adjustments	(5,212		)	319
	Balance, end of period	$	177,820		$	135,184
	Additions to goodwill represent goodwill from acquisitions made during the period. Adjustments to goodwill include translation adjustments resulting from a portion of our goodwill being recorded on the books of our foreign subsidiaries as well as minor adjustments made for the finalization of the purchase price allocations.
	Acquisition of Lithicon AS
	On February 5, 2014 we acquired 100% of the outstanding shares of Lithicon AS (“Lithicon”), which has operations in Norway and Australia. Lithicon provides digital rock technology services and pore-scale micro computed tomography (“microCT”) equipment to oil and gas companies. In conjunction with the acquisition we have obtained the helical scan microCT product and associated software from the Australian National University through a licensing and development agreement.
	The total purchase price of the acquisition was $68.0 million, plus an adjustment for the change in final closing accounts of $0.4 million. We paid $0.4 million in transaction costs, of which $0.3 million was paid in the first quarter. Those costs were expensed as incurred and are recorded in selling, general and administrative costs on the Consolidated Statements of Operations. The total purchase price was allocated to the net tangible and intangible assets acquired based on their preliminary fair values as of February 5, 2014. The fair value of net tangible assets acquired was $7.7 million and the fair value of net intangible assets acquired was $22.0 million, which consisted of $18.6 million in developed technology, $2.2 million of customer relationships and $1.2 million of purchased backlog. Including an increase to net deferred tax liabilities of $8.1 million, the excess of the purchase price over the fair value of the net assets acquired was $46.9 million, which was recorded as goodwill in the Industry Group. For the thirteen and thirty-nine week periods ended September 28, 2014 the acquired business added $1.9 million and $4.3 million of revenue, respectively, and a net loss of $1.0 million and $3.1 million, respectively, to our consolidated financial results.
	The goodwill arising from the acquisition of Lithicon is primarily related to expected future cash flows from expansion of our product offerings in the oil and gas market to include digital rock services, as well as synergies from the introduction of the microCT product to the existing FEI product suite.
	The acquired developed technology, customer relationships and purchased backlog will be amortized over a period of 10 years, 5 years and 2 years, respectively.
	No pro forma financial information has been provided for this acquisition as it is insignificant.
	Other Intangible Assets
	Patents, trademarks and other are amortized using the straight-line method over their estimated useful lives of 2 to 10 years. Customer relationships are amortized using the straight-line method over their estimated useful lives of 5 to 10 years. Developed technology is amortized using the straight-line method over the estimated useful life of the related technology, which ranges from 5.5 to 10 years. Note issuance costs were amortized over the life of the related debt, which was 7 years.
	The gross amount of our other intangible assets and the related accumulated amortization were as follows (in thousands):
		September 28,			December 31,
		2014			2013
	Patents, trademarks and other	$	25,786		$	24,327
	Accumulated amortization	(12,354		)	(9,296		)
	Net patents, trademarks and other	13,432			15,031
	Customer relationships	22,809			21,650
	Accumulated amortization	(5,428		)	(3,547		)
	Net customer relationships	17,381			18,103
	Developed technology	35,562			18,161
	Accumulated amortization	(7,004		)	(4,098		)
	Net developed technology	28,558			14,063
	Note issuance costs	2,445			2,445
	Accumulated amortization	(2,445		)	(2,445		)
	Net note issuance costs	—			—
	Total intangible assets included in other long-term assets	$	59,371		$	47,197
	Amortization expense was as follows (in thousands):
		Thirty-Nine Weeks Ended
		September 28,			September 29,
		2014			2013
	Patents, trademarks and other	$	3,850		$	2,527
	Customer relationships	1,882			1,728
	Developed technology	2,906			1,718
	Note issuance costs	—			146
	Total amortization expense	$	8,638		$	6,119
	Expected amortization, without consideration for foreign currency effects, is as follows over the next five years and thereafter (in thousands):
		Patents,			Customer Relationships			Developed Technology		Total
		Trademarks
		and Other
	Remainder of 2014	$	826		$	688		$	1,004	$	2,518
	2015	3,643			2,749			4,016		10,408
	2016	2,702			2,749			4,016		9,467
	2017	2,262			2,401			3,756		8,419
	2018	1,661			2,321			3,387		7,369
	Thereafter	2,338			6,473			12,379		21,190
	Total future amortization expense	$	13,432		$	17,381		$	28,558	$	59,371

Warranty_Reserves

Warranty Reserves	9 Months Ended
	Sep. 28, 2014
Product Warranties Disclosures [Abstract]	'
Warranty Reserves	'
	WARRANTY RESERVES
	Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades as a component of cost of sales on our consolidated statements of operations. Our estimate of warranty cost is primarily based on our history of warranty repairs and maintenance, as applied to systems currently under warranty. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past. Our estimated warranty costs are reviewed and updated on a quarterly basis. Changes to the reserve occur as volume, product mix and warranty costs fluctuate.
	The following is a summary of warranty reserve activity (in thousands):
		Thirty-Nine Weeks Ended
		September 28,			September 29,
		2014			2013
	Balance, beginning of period	$	12,705		$	12,049
	Reductions for warranty costs incurred	(10,132		)	(9,478		)
	Warranties issued	9,826			9,776
	Translation and changes in estimates	(271		)	3
	Balance, end of period	$	12,128		$	12,350

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 28, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	Our tax provision for the thirteen and thirty-nine week periods ended September 28, 2014 consisted primarily of taxes accrued in the U.S. and foreign jurisdictions, offset by a reduction of unrecognized tax benefits due primarily to settlements with taxing authorities. We continue to record a valuation allowance against a portion of our U.S. and foreign deferred tax assets as we do not believe it is more likely than not that we will be able to utilize the deferred tax assets in future periods.
	Deferred Income Taxes
	Net deferred tax assets were classified on the balance sheet as follows (in thousands):
		September 28,			December 31,
		2014			2013
	Deferred tax assets – current	$	9,890		$	15,114
	Deferred tax assets – non-current	9,156			1,751
	Deferred tax liabilities – current	(51		)	(9		)
	Deferred tax liabilities – non-current	(10,405		)	(8,931		)
	Net deferred tax assets	$	8,590		$	7,925
	Valuation allowance	$	4,429		$	2,723
	Unrecognized Tax Benefits
	During the thirteen and thirty-nine week periods ended September 28, 2014, unrecognized tax benefits, interest and penalties decreased by $2.6 million and $3.1 million, respectively, primarily due to the lapse of statutes of limitation and settlements with taxing authorities, which were partially offset by additional uncertainty surrounding permanent establishment and transfer pricing in various foreign jurisdictions. We recognize interest and penalties related to unrecognized tax benefits in tax expense.
	For our major tax jurisdictions, the following years were open for examination by the tax authorities as of September 28, 2014:
	Jurisdiction		Open Tax Years
	U.S.		2011 and forward
	The Netherlands		2011 and forward
	Czech Republic		2011 and forward

RelatedParty_Activity

Related-Party Activity	9 Months Ended
	Sep. 28, 2014
Related Party Transactions [Abstract]	'
Related-Party Activity	'
	RELATED-PARTY ACTIVITY
	Related parties with which we had transactions during the thirteen and thirty-nine week periods ended September 28, 2014 were as follows:
	•	one of the members of our Board of Directors serves on the Board of Directors of Applied Materials, Inc. and Lattice Semiconductor Corporation;
	•	our Chief Financial Officer is on the Board of Directors of Cascade Microtech, Inc.;
	•	one of the members of our Board of Directors serves on the Supervisory Board of TMC BV; and
	•	our Chief Executive Officer is on the Board of Trustees for the Oregon Health and Science University Foundation.
	Transactions with these related parties were as follows (in thousands):
		Thirteen Weeks Ended					Thirty-Nine Weeks Ended
	Sales to Related Parties	September 28,			September 29,		September 28,		September 29,
		2014			2013		2014		2013
	Product sales:
	Applied Materials, Inc.	$	230		$	1,039	$	2,572	$	4,630
	Lattice Semiconductor Corporation	—			—		—		4
	Oregon Health and Science University	77			130		326		385
	Total product sales to related parties	307			1,169		2,898		5,019
	Service sales:
	Applied Materials, Inc.	256			220		611		550
	Lattice Semiconductor Corporation	3			3		9		9
	Cascade Microtech, Inc.	9			8		25		24
	Oregon Health and Science University	83			14		258		30
	Total service sales to related parties	351			245		903		613
	Total sales to related parties	$	658		$	1,414	$	3,801	$	5,632
	Purchases from Related Parties
	TMC BV	$	395		$	27	$	1,685	$	75
	Oregon Health and Science University	41			39		119		214
	Total purchases from related parties	$	436		$	66	$	1,804	$	289
	Amounts due from (to) related parties were as follows (in thousands):
		September 28,
		2014
	Applied Materials, Inc.	$	433
	Cascade Microtech, Inc.	8
	TMC BV	(75		)
	Oregon Health and Science University	4
	Due from related parties, net	$	370

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 28, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	COMMITMENTS AND CONTINGENCIES
	From time to time, we may be a party to litigation arising in the ordinary course of business. Currently, we are not a party to any litigation that we believe would have a material adverse effect on our financial position, results of operations or cash flows.
	Purchase Obligations
	We have commitments under non-cancelable purchase orders, primarily relating to inventory, totaling $80.0 million at September 28, 2014. These commitments expire at various times through the second quarter of 2016.

Segment_Information

Segment Information	9 Months Ended
	Sep. 28, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	SEGMENT INFORMATION
	Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is our Chief Executive Officer.
	We currently report our segments based on a group structure organization. Our segments are Industry Group and Science Group.
	The following tables summarize various financial amounts for each of our business segments (in thousands):
		Thirteen Weeks Ended				Thirty-Nine Weeks Ended
		September 28,		September 29,		September 28,		September 29,
		2014		2013		2014		2013
	Sales to External Customers:
	Industry Group	$	107,058	$	103,627	$	340,722	$	306,393
	Science Group	120,698		114,869		350,254		355,770
	Total	$	227,756	$	218,496	$	690,976	$	662,163
	Gross Profit:
	Industry Group	$	55,101	$	56,216	$	175,321	$	160,517
	Science Group	53,480		48,529		149,435		153,676
	Total	$	108,581	$	104,745	$	324,756	$	314,193
		September 28,		December 31,
		2014		2013
	Goodwill:
	Industry Group	$	97,598	$	51,532
	Science Group	80,222		84,620
	Total	$	177,820	$	136,152
	Total Assets:
	Industry Group	$	403,355	$	297,987
	Science Group	346,578		365,571
	Corporate and Eliminations	689,583		762,526
	Total	$	1,439,516	$	1,426,084
	Market segment disclosures are presented to the gross profit level as this is the primary performance measure for which the segment general managers are responsible. Selling, general and administrative, research and development and other operating expenses are managed and reported at the corporate level and, because allocation to the market segments would be arbitrary, have not been allocated to the market segments. See the Consolidated Statements of Operations for reconciliations from gross profit to income before income taxes. These reconciling items are not included in the measure of profit and loss for each reportable segment.

Restructuring_Reorganization_R

Restructuring, Reorganization, Relocation and Severance	9 Months Ended
	Sep. 28, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring, Reorganization, Relocation and Severance	'
	RESTRUCTURING, REORGANIZATION, RELOCATION AND SEVERANCE
	Second Quarter 2014 Realignment
	During the second quarter of 2014, we began to implement a resource realignment plan that will cause us to incur expenses during the remainder of 2014. The realignment plan aims to improve our operational efficiency by eliminating redundancies in sites and personnel resulting from recent acquisitions and expansion activities. We intend to shift our resources to growing regions, such as Asia, and potential growth markets, such as structural biology, oil and gas, near-line semiconductor processing and metals research, and expect the realignment plan to better position us to pursue our growth strategy. The realignment plan activities currently include the consolidation of our three Australia sites in Canberra; the closure of our facility in Delmont, Pennsylvania and relocation of those operations to our new facility in the Czech Republic; relocation of our Japan demonstration facility to our Shanghai facility; selective reductions in staffing, relocations and compensation adjustments related to the foregoing activities and other realignment of management resources.
	The following table summarizes the costs incurred under our second quarter realignment plan:
		Thirteen Weeks Ended						Thirty-Nine Weeks Ended
	Realignment Costs	September 28,			June 29,			September 28,
		2014			2014			2014
	Inventory write-offs	$	230		$	755		$	985
	Acceleration of acquisition-related earn-out	—			2,500			2,500
	Impairment and other asset write-offs	1,831			466			2,297
	Restructuring activities	7,699			2,228			11,259
	Total	$	9,760		$	5,949		$	17,041
	These costs have been recorded in our Consolidated Statements of Operations as follows:
		Thirteen Weeks Ended						Thirty-Nine Weeks Ended
	Statement of Operations Classification	September 28,			June 29,			September 28,
		2014			2014			2014
	Cost of sales	$	230		$	755		$	985
	Selling, general and administrative	1,831			2,966			4,797
	Restructuring, reorganization and relocation	7,699			2,228			11,259
	Total	$	9,760		$	5,949		$	17,041
	The total cost of the realignment plan, including costs to move to our new facility in the Czech Republic, is estimated to be between $24.0 million and $26.0 million, with all costs to be incurred during 2014. Savings from the realignment plan are expected to be approximately $10.0 million on an annual basis.
	First Quarter 2014 Restructuring
	During the first quarter of 2014, we engaged in a restructuring plan principally aimed at consolidating our sales force in Europe. The $1.3 million cost incurred in implementing the restructuring plan primarily consisted of severance and other employee termination related costs, and was incurred during the first quarter of 2014. We do not expect to incur any additional costs under this plan. Savings from this plan are expected to be approximately $1.8 million on an annual basis.
	Group Structure Reorganization
	During the first quarter of 2013, we reorganized the company into a group structure in order to enable us to efficiently execute our growth strategy. The costs associated with the reorganization consisted primarily of severance costs and resulted in the termination of certain positions throughout the company. In anticipation of this reorganization, we incurred $2.9 million of costs during the fourth quarter of 2012, and recorded $1.1 million of severance costs during 2013, for a total cost of $4.0 million. We do not expect to incur any additional costs under this reorganization plan.
	Restructuring, Reorganization, Relocation and Severance Accrual
	The following table summarizes the charges, expenditures, write-offs and adjustments related to our restructuring, reorganization, relocation and severance accrual (in thousands):
	Thirty-Nine Weeks Ended September 28, 2014	Second Quarter 2014 Realignment			First Quarter 2014 Restructuring			Group Structure Reorganization			Total
	Beginning accrued liability	$	—		$	—		$	50		$	50
	Charged to expense, net	9,928			1,331			—			11,259
	Expenditures	(3,466		)	(1,331		)	(50		)	(4,847		)
	Ending accrued liability	$	6,462		$	—		$	—		$	6,462
	Thirty-Nine Weeks Ended September 29, 2013	Group Structure Organization			Total
	Beginning accrued liability	$	2,692		$	2,692
	Charged to expense, net	1,090			1,090
	Expenditures	(3,466		)	(3,466		)
	Write-offs and adjustments	50			50
	Ending accrued liability	$	366		$	366

Fair_Value_Measurements_of_Ass

Fair Value Measurements of Assets and Liabilities	9 Months Ended
	Sep. 28, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements of Assets and Liabilities	'
	FAIR VALUE MEASUREMENTS OF ASSETS AND LIABILITIES
	Factors used in determining the fair value of our financial assets and liabilities are summarized into three broad categories:
	•	Level 1 – quoted prices in active markets for identical securities as of the reporting date;
	•	Level 2 – other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; and
	•	Level 3 – significant inputs that are generally less observable than objective sources, including our own assumptions in determining fair value.
	The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
	Following are the disclosures related to the fair value of our financial assets and (liabilities) (in thousands):
	September 28, 2014	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. Government-backed securities	$	12,618	$	—		$	—	$	12,618
	Agency bonds	—		51,958			—		51,958
	Commercial paper	—		39,332			—		39,332
	Certificates of deposit	—		17,274			—		17,274
	Municipal bonds	—		31,547			—		31,547
	Corporate bonds	—		9,920			—		9,920
	Trading securities:
	Equity securities – mutual funds	6,945		—			—		6,945
	Derivative contracts, net	—		(4,307		)	—		(4,307		)
	Total	$	19,563	$	145,724		$	—	$	165,287
	December 31, 2013	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. treasury notes	$	10,128	$	—		$	—	$	10,128
	Agency bonds	—		37,961			—		37,961
	Commercial paper	—		39,987			—		39,987
	Certificates of deposit	—		7,786			—		7,786
	Municipal bonds	—		49,319			—		49,319
	Corporate bonds	—		5,001			—		5,001
	Trading securities:
	Equity securities – mutual funds	5,287		—			—		5,287
	Derivative contracts, net	—		(1,113		)	—		(1,113		)
	Total	$	15,415	$	138,941		$	—	$	154,356
	Agency bonds are securities backed by U.S. government-sponsored entities. U.S. Government-backed securities include Treasury Bills and Treasury Notes.
	We use an income approach to value the assets and liabilities for outstanding derivative contracts using current market information as of the reporting date, such as spot rates, interest rate differentials and implied volatility.
	There were no transfers between fair value categories or changes to our valuation techniques during the thirty-nine weeks ended September 28, 2014.
	We believe the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and other current liabilities are a reasonable approximation of the fair value of those financial instruments because of the nature of the underlying transactions and the short-term maturities involved.

Derivative_Instruments

Derivative Instruments	9 Months Ended
	Sep. 28, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments	'
	DERIVATIVE INSTRUMENTS
	In the normal course of business, we are exposed to foreign currency risk and we use derivatives to mitigate financial exposure from movements in foreign currency exchange rates.
	The aggregate notional amount of outstanding derivative contracts were as follows (in thousands):
		September 28,				December 31,
		2014				2013
	Cash flow hedges	$	256,000			$	208,446
	Balance sheet hedges	179,835				172,947
	Total outstanding derivative contracts	$	435,835			$	381,393
	The outstanding contracts at September 28, 2014 have varying maturities through the first quarter of 2016. We do not enter into derivative financial instruments for speculative purposes.
	We attempt to mitigate derivative credit risk by transacting with highly rated counterparties. We have evaluated the credit and nonperformance risks associated with our derivative counterparties and believe them to be insignificant and not warranting a credit adjustment at September 28, 2014. In addition, there are no credit contingent features in our derivative instruments.
	Balance Sheet Related
	In countries outside of the U.S., we transact business in U.S. dollars and in various other currencies. We attempt to mitigate our currency exposures for recorded transactions by using forward exchange contracts to reduce the risk that our future cash flows will be adversely affected by changes in exchange rates. We enter into forward sale or purchase contracts for foreign currencies to economically hedge specific cash, receivables or payables positions denominated in foreign currencies.
	Changes in fair value of derivatives entered into to mitigate the foreign exchange risks related to these balance sheet items are recorded in other income (expense) together with the transaction gain or loss from the respective balance sheet position as follows (in thousands):
		Thirteen Weeks Ended								Thirty-Nine Weeks Ended
		September 28,				September 29,				September 28,				September 29,
		2014				2013				2014				2013
	Foreign currency loss, inclusive of the impact of derivatives	$	(644	)		$	(638	)		$	(1,597	)		$	(2,164	)
	Cash Flow Hedges
	We use zero cost collar contracts and option contracts to hedge certain anticipated foreign currency exchange transactions. The foreign exchange hedging structure may extend, generally, up to a twenty-four month time horizon. The hedging transactions we undertake primarily limit our exposure to changes in the U.S. dollar/euro and the U.S. dollar/Czech koruna exchange rate. The zero cost collar contract hedges are designed to protect us as the U.S. dollar weakens, but also provide us with some flexibility if the dollar strengthens.
	These derivatives meet the criteria to be designated as hedges and, accordingly, we record the change in fair value of the effective portion of these hedge contracts relating to anticipated transactions in other comprehensive income rather than net income until the underlying hedged transaction affects net income. Gains and losses resulting from the ineffective portion of the hedge contracts, if any, are recognized as a component of net income. Gains and losses related to cash flow derivative contracts not designated as hedging instruments are recorded as a component of net income.
	Summary
	Our derivative instruments are subject to master netting arrangements and are presented net in our balance sheet. We do not have any financial collateral related to these netting arrangements. The effect of these netting arrangements on our balance sheet is as follows (in thousands):
		Offsetting of Derivative Assets										Offsetting of Derivative Liabilities
	September 28, 2014	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets				Gross Amounts of Recognized Liabilities			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—			$	4,674		$	(1,428	)	$	3,246
	Foreign exchange contracts not designated as hedging instruments	1,598			(473		)	1,125				4,167			(1,981		)	2,186
	Total	$	1,598		$	(473	)	$	1,125			$	8,841		$	(3,409	)	$	5,432
		Offsetting of Derivative Assets										Offsetting of Derivative Liabilities
	December 31, 2013	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets				Gross Amounts of Recognized Liabilities			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—			$	4,362		$	(3,042	)	$	1,320
	Foreign exchange contracts not designated as hedging instruments	2,171			(698		)	1,473				2,916			(1,650		)	1,266
	Total	$	2,171		$	(698	)	$	1,473			$	7,278		$	(4,692	)	$	2,586
	The effect of derivative instruments was as follows (in thousands):
		Thirteen Weeks Ended								Thirty-Nine Weeks Ended
	Foreign Exchange Contracts in Cash Flow Hedging Relationships	September 28,				September 29,				September 28,				September 29,
		2014				2013				2014				2013
	Amount of gain/(loss):
	Recognized in AOCI (effective portion)	$	(6,757	)		$	(637	)		$	(11,016	)		$	(3,567	)
	Reclassified from AOCI into revenue (effective portion)	1				—				47				—
	Reclassified from AOCI into cost of sales (effective portion)	(2,486		)		120				(4,152		)		(460		)
	Recognized in other, net (ineffective portion and amount excluded from effectiveness testing)	(49		)		—				(58		)		(46		)
	Foreign Exchange Contracts Not in Cash Flow Hedging Relationships
	Amount of gain/(loss):
	Recognized in other, net	$	2,018			$	(491	)		$	5,763			$	3,582
	The unrealized losses at September 28, 2014 are expected to be reclassified to net income during the next eighteen months as a result of the underlying hedged transactions also being recorded in net income.

Changes_in_Accumulated_Other_C

Changes in Accumulated Other Comprehensive Income by Component	9 Months Ended
	Sep. 28, 2014
Changes in Accumulated Other Comprehensive Income [Abstract]	'
Changes in Accumulated Other Comprehensive Income by Component	'
	CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
	The following tables illustrate the disclosure of changes in the balances of each component of accumulated other comprehensive income (“AOCI”), as well as details the effect of reclassifications out of AOCI on the line items in the Consolidated Statements of Operations by component (net of tax, in thousands):
		Thirteen Weeks Ended September 28, 2014
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	47,109		$	29		$	(519	)	$	(1,320	)	$	45,299
	Other comprehensive income before reclassifications	(37,778		)	(52		)	45			(5,475		)	(43,260		)
	Amounts reclassified from AOCI to:
	Revenue	—			—			—			(1		)	(1		)
	Cost of goods sold	—			—			—			2,486			2,486
	Other income (expense)	—			—			—			49			49
	Total reclassifications out of AOCI	—			—			—			2,534			2,534
	Net current period other comprehensive income	(37,778		)	(52		)	45			(2,941		)	(40,726		)
	Ending balance	$	9,331		$	(23	)	$	(474	)	$	(4,261	)	$	4,573
		Thirty-Nine Weeks Ended September 28, 2014
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	48,865		$	(11	)	$	(552	)	$	(1,174	)	$	47,128
	Other comprehensive income before reclassifications	(39,534		)	(12		)	78			(7,250		)	(46,718		)
	Amounts reclassified from AOCI to:
	Revenue	—			—			—			(47		)	(47		)
	Cost of goods sold	—			—			—			4,152			4,152
	Other income (expense)	—			—			—			58			58
	Total reclassifications out of AOCI	—			—			—			4,163			4,163
	Net current period other comprehensive income	(39,534		)	(12		)	78			(3,087		)	(42,555		)
	Ending balance	$	9,331		$	(23	)	$	(474	)	$	(4,261	)	$	4,573
		Thirteen Weeks Ended September 29, 2013
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	29,537		$	1		$	(890	)	$	(748	)	$	27,900
	Other comprehensive income before reclassifications	17,126			24			(70		)	1,292			18,372
	Amounts reclassified from AOCI to:
	Cost of goods sold	—			—			—			(120		)	(120		)
	Total reclassifications out of AOCI	—			—			—			(120		)	(120		)
	Net current period other comprehensive income	17,126			24			(70		)	1,172			18,252
	Ending balance	$	46,663		$	25		$	(960	)	$	424		$	46,152
		Thirty-Nine Weeks Ended September 29, 2013
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	38,890		$	4		$	(819	)	$	481		$	38,556
	Other comprehensive income before reclassifications	7,773			21			(141		)	(563		)	7,090
	Amounts reclassified from AOCI to:
	Cost of goods sold	—			—			—			460			460
	Other income (expense)	—			—			—			46			46
	Total reclassifications out of AOCI	—			—			—			506			506
	Net current period other comprehensive income	7,773			21			(141		)	(57		)	7,596
	Ending balance	$	46,663		$	25		$	(960	)	$	424		$	46,152

Factoring_of_Accounts_Receivab

Factoring of Accounts Receivable	9 Months Ended
	Sep. 28, 2014
Factoring of Accounts Receivable [Abstract]	'
Factoring of Accounts Receivable	'
	FACTORING OF ACCOUNTS RECEIVABLE
	We entered into agreements under which we sold a total of $3.0 million and $7.0 million of our accounts receivable at a discount to unrelated third party financiers without recourse during the thirteen and thirty-nine week periods ended September 28, 2014, respectively. The transfers qualified for sales treatment and, accordingly, discounts related to the sale of the receivables, which were immaterial, were recorded on our Consolidated Statements of Operations as other expense. We sold $3.2 million and $8.1 million of accounts receivable under similar arrangements during the thirteen and thirty-nine week periods ended September 29, 2013, respectively.

New_Accounting_Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 28, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
New Accounting Pronouncements	'
	NEW ACCOUNTING PRONOUNCEMENTS
	ASU 2014-15
	On August 27, 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s  Ability to Continue as a Going Concern. The update provides US GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU, however, at the current period, management does not believe that it has met conditions which would subject these consolidated financial statements for additional disclosure.
	ASU 2014-09
	On May 28, 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard will become effective for us on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Organization_and_Basis_of_Pres1

Organization and Basis of Presentation (Policies)	9 Months Ended
	Sep. 28, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Consolidation Policy	'
	The consolidated financial statements include the accounts of FEI Company and our wholly-owned subsidiaries (collectively, “FEI”). All significant intercompany balances and transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements and condensed footnotes have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments considered necessary for fair presentation have been included. The results of operations for the
Use of Estimates Policy	'
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.
	Significant accounting policies and estimates underlying the accompanying consolidated financial statements include:
Restricted Cash Policy	'
	As part of our contracts with certain customers, we are required to provide letters of credit or bank guarantees which these customers can draw against in the event we do not perform in accordance with our contractual obligations. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets.
	The following table sets forth information related to guarantees and letters of credit (in thousands):
		September 28,
		2014
	Guarantees and letters of credit outstanding	$	51,817
	Amount secured by restricted cash deposits:
	Current	$	11,988
	Long-term	38,953
	Total secured by restricted cash	$	50,941
Inventories Policy	'
	Inventories are stated at the lower of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as a long-term asset. Management has established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory.
Intangible Assets Policy	'
	Patents, trademarks and other are amortized using the straight-line method over their estimated useful lives of 2 to 10 years. Customer relationships are amortized using the straight-line method over their estimated useful lives of 5 to 10 years. Developed technology is amortized using the straight-line method over the estimated useful life of the related technology, which ranges from 5.5 to 10 years. Note issuance costs were amortized over the life of the related debt, which was 7 years.
Warranty Liabilities Policy	'
	Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades as a component of cost of sales on our consolidated statements of operations. Our estimate of warranty cost is primarily based on our history of warranty repairs and maintenance, as applied to systems currently under warranty. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past. Our estimated warranty costs are reviewed and updated on a quarterly basis. Changes to the reserve occur as volume, product mix and warranty costs fluctuate.

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	9 Months Ended
	Sep. 28, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share Reconciliation	'
	Following is a reconciliation of basic earnings per share (“EPS”) and diluted EPS (in thousands, except per share amounts):
		Thirteen Weeks Ended								Thirteen Weeks Ended
		September 28, 2014								September 29, 2013
		Net			Shares		Per Share			Net		Shares	Per Share
		Income					Amount			Income			Amount
	Basic EPS	$	21,647		41,891		$	0.52		$	28,606	41,750	$	0.69
	Dilutive effect of 2.875% convertible debt	—			—		—			—		—	—
	Dilutive effect of stock options, restricted stock units, and shares issuable to Philips	—			574		(0.01		)	—		705	(0.02		)
	Diluted EPS	$	21,647		42,465		$	0.51		$	28,606	42,455	$	0.67
		Thirty-Nine Weeks Ended								Thirty-Nine Weeks Ended
		September 28, 2014								September 29, 2013
		Net			Shares		Per Share			Net		Shares	Per Share
		Income					Amount			Income			Amount
	Basic EPS	$	71,671		42,053		$	1.7		$	85,400	39,928	$	2.14
	Dilutive effect of 2.875% convertible debt	—			—		—			780		1,727	(0.07		)
	Dilutive effect of stock options, restricted stock units, and shares issuable to Philips	—			571		(0.02		)	—		645	(0.03		)
	Diluted EPS	$	71,671		42,624		$	1.68		$	86,180	42,300	$	2.04
Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share	'
	The following table sets forth the schedule of anti-dilutive securities excluded from the computation of diluted EPS (number of shares, in thousands):
		Thirteen Weeks Ended				Thirty-Nine Weeks Ended
		September 28,		September 29,		September 28,			September 29,
		2014		2013		2014			2013
	Stock options	361		31		246			220
	Restricted stock units	10		1		8			1

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 28, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Information Related to Stock-Based Compensation Plans	'
	The following table sets forth certain information regarding the 1995 Plan:
		September 28,
		2014
	Shares available for grant	1,876,336
	Shares of common stock reserved for issuance [pursuant to outstanding exercisable securities]	3,578,885
Schedule of Options Outstanding and Exercisable	'
	The following table sets forth certain information regarding all options outstanding and exercisable:
		September 28, 2014
		Options		Options
		Outstanding		Exercisable
	Number	866,618		173,889
	Weighted average exercise price	$	60.2	$	38.69
	Aggregate intrinsic value	$ 17.9 million		$ 6.9 million
	Weighted average remaining contractual term	5.1 years		3.6 years
Schedule of Restricted Stock Units Nonvested and Expected to Vest	'
	The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
		September 28, 2014
		RSUs Nonvested		RSUs Expected
				to Vest
	Number	835,933		750,036
	Weighted average grant date per share fair value	$	63.75	$	62.68
	Aggregate intrinsic value	$ 65.3 million		$ 58.6 million
	Weighted average remaining term to vest	1.3 years		1.2 years
Schedule of Stock-Based Compensation Expense	'
	Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands):
		Thirteen Weeks Ended				Thirty-Nine Weeks Ended
		September 28,		September 29,		September 28,		September 29,
		2014		2013		2014		2013
	Cost of sales	$	912	$	571	$	2,495	$	1,782
	Research and development	762		511		2,092		1,587
	Selling, general and administrative	4,820		3,522		12,869		9,947
	Total stock-based compensation	$	6,494	$	4,604	$	17,456	$	13,316

Credit_Facilities_and_Restrict1

Credit Facilities and Restricted Cash (Tables)	9 Months Ended
	Sep. 28, 2014
Credit Facilities And Restricted Cash	'
Schedule of Letters of Credit and Restricted Cash	'
	The following table sets forth information related to guarantees and letters of credit (in thousands):
		September 28,
		2014
	Guarantees and letters of credit outstanding	$	51,817
	Amount secured by restricted cash deposits:
	Current	$	11,988
	Long-term	38,953
	Total secured by restricted cash	$	50,941

Inventories_Tables

Inventories (Tables)	9 Months Ended
	Sep. 28, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventories	'
	Inventories consisted of the following (in thousands):
		September 28,		December 31,
		2014		2013
	Raw materials and assembled parts	$	60,219	$	61,235
	Service inventories, estimated current requirements	13,208		15,197
	Work-in-process	83,475		75,883
	Finished goods	33,492		29,410
	Total current inventories	$	190,394	$	181,725
	Non-current inventories	$	53,845	$	62,104

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 28, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill Activity	'
	The roll-forward of activity related to our goodwill was as follows (in thousands):
		Thirty-Nine Weeks Ended
		September 28,			September 29,
		2014			2013
	Balance, beginning of period	$	136,152		$	131,320
	Goodwill additions	46,880			3,545
	Goodwill adjustments	(5,212		)	319
	Balance, end of period	$	177,820		$	135,184
Schedule of Finite-Lived Intangible Assets by Major Class	'
	The gross amount of our other intangible assets and the related accumulated amortization were as follows (in thousands):
		September 28,			December 31,
		2014			2013
	Patents, trademarks and other	$	25,786		$	24,327
	Accumulated amortization	(12,354		)	(9,296		)
	Net patents, trademarks and other	13,432			15,031
	Customer relationships	22,809			21,650
	Accumulated amortization	(5,428		)	(3,547		)
	Net customer relationships	17,381			18,103
	Developed technology	35,562			18,161
	Accumulated amortization	(7,004		)	(4,098		)
	Net developed technology	28,558			14,063
	Note issuance costs	2,445			2,445
	Accumulated amortization	(2,445		)	(2,445		)
	Net note issuance costs	—			—
	Total intangible assets included in other long-term assets	$	59,371		$	47,197
Schedule of Amortization Expense by Major Class	'
	Amortization expense was as follows (in thousands):
		Thirty-Nine Weeks Ended
		September 28,			September 29,
		2014			2013
	Patents, trademarks and other	$	3,850		$	2,527
	Customer relationships	1,882			1,728
	Developed technology	2,906			1,718
	Note issuance costs	—			146
	Total amortization expense	$	8,638		$	6,119
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	Expected amortization, without consideration for foreign currency effects, is as follows over the next five years and thereafter (in thousands):
		Patents,			Customer Relationships			Developed Technology		Total
		Trademarks
		and Other
	Remainder of 2014	$	826		$	688		$	1,004	$	2,518
	2015	3,643			2,749			4,016		10,408
	2016	2,702			2,749			4,016		9,467
	2017	2,262			2,401			3,756		8,419
	2018	1,661			2,321			3,387		7,369
	Thereafter	2,338			6,473			12,379		21,190
	Total future amortization expense	$	13,432		$	17,381		$	28,558	$	59,371

Warranty_Reserves_Tables

Warranty Reserves (Tables)	9 Months Ended
	Sep. 28, 2014
Product Warranties Disclosures [Abstract]	'
Schedule of Warranty Reserve Activity	'
	The following is a summary of warranty reserve activity (in thousands):
		Thirty-Nine Weeks Ended
		September 28,			September 29,
		2014			2013
	Balance, beginning of period	$	12,705		$	12,049
	Reductions for warranty costs incurred	(10,132		)	(9,478		)
	Warranties issued	9,826			9,776
	Translation and changes in estimates	(271		)	3
	Balance, end of period	$	12,128		$	12,350

Income_Taxes_Tables

Income Taxes (Tables)	9 Months Ended
	Sep. 28, 2014
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities, Balance Sheet Classification	'
	Net deferred tax assets were classified on the balance sheet as follows (in thousands):
		September 28,			December 31,
		2014			2013
	Deferred tax assets – current	$	9,890		$	15,114
	Deferred tax assets – non-current	9,156			1,751
	Deferred tax liabilities – current	(51		)	(9		)
	Deferred tax liabilities – non-current	(10,405		)	(8,931		)
	Net deferred tax assets	$	8,590		$	7,925
	Valuation allowance	$	4,429		$	2,723
Open Tax Years By Major Tax Jurisdiction	'
	For our major tax jurisdictions, the following years were open for examination by the tax authorities as of September 28, 2014:
	Jurisdiction		Open Tax Years
	U.S.		2011 and forward
	The Netherlands		2011 and forward
	Czech Republic		2011 and forward

RelatedParty_Activity_Tables

Related-Party Activity (Tables)	9 Months Ended
	Sep. 28, 2014
Related Party Transactions [Abstract]	'
Schedule of Transactions with Related Parties	'
	Transactions with these related parties were as follows (in thousands):
		Thirteen Weeks Ended					Thirty-Nine Weeks Ended
	Sales to Related Parties	September 28,			September 29,		September 28,		September 29,
		2014			2013		2014		2013
	Product sales:
	Applied Materials, Inc.	$	230		$	1,039	$	2,572	$	4,630
	Lattice Semiconductor Corporation	—			—		—		4
	Oregon Health and Science University	77			130		326		385
	Total product sales to related parties	307			1,169		2,898		5,019
	Service sales:
	Applied Materials, Inc.	256			220		611		550
	Lattice Semiconductor Corporation	3			3		9		9
	Cascade Microtech, Inc.	9			8		25		24
	Oregon Health and Science University	83			14		258		30
	Total service sales to related parties	351			245		903		613
	Total sales to related parties	$	658		$	1,414	$	3,801	$	5,632
	Purchases from Related Parties
	TMC BV	$	395		$	27	$	1,685	$	75
	Oregon Health and Science University	41			39		119		214
	Total purchases from related parties	$	436		$	66	$	1,804	$	289
Schedule of Amounts Due From (To) Related Parties	'
	Amounts due from (to) related parties were as follows (in thousands):
		September 28,
		2014
	Applied Materials, Inc.	$	433
	Cascade Microtech, Inc.	8
	TMC BV	(75		)
	Oregon Health and Science University	4
	Due from related parties, net	$	370

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 28, 2014
Segment Reporting [Abstract]	'
Schedule of Sales to External Customers and Gross Profit by Segment	'
	The following tables summarize various financial amounts for each of our business segments (in thousands):
		Thirteen Weeks Ended				Thirty-Nine Weeks Ended
		September 28,		September 29,		September 28,		September 29,
		2014		2013		2014		2013
	Sales to External Customers:
	Industry Group	$	107,058	$	103,627	$	340,722	$	306,393
	Science Group	120,698		114,869		350,254		355,770
	Total	$	227,756	$	218,496	$	690,976	$	662,163
	Gross Profit:
	Industry Group	$	55,101	$	56,216	$	175,321	$	160,517
	Science Group	53,480		48,529		149,435		153,676
	Total	$	108,581	$	104,745	$	324,756	$	314,193
Schedule of Goodwill and Total Assets by Segment	'
		September 28,		December 31,
		2014		2013
	Goodwill:
	Industry Group	$	97,598	$	51,532
	Science Group	80,222		84,620
	Total	$	177,820	$	136,152
	Total Assets:
	Industry Group	$	403,355	$	297,987
	Science Group	346,578		365,571
	Corporate and Eliminations	689,583		762,526
	Total	$	1,439,516	$	1,426,084

Restructuring_Reorganization_R1

Restructuring, Reorganization, Relocation and Severance (Tables)	9 Months Ended
	Sep. 28, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Costs [Table Text Block]	'
	The following table summarizes the costs incurred under our second quarter realignment plan:
		Thirteen Weeks Ended						Thirty-Nine Weeks Ended
	Realignment Costs	September 28,			June 29,			September 28,
		2014			2014			2014
	Inventory write-offs	$	230		$	755		$	985
	Acceleration of acquisition-related earn-out	—			2,500			2,500
	Impairment and other asset write-offs	1,831			466			2,297
	Restructuring activities	7,699			2,228			11,259
	Total	$	9,760		$	5,949		$	17,041
	These costs have been recorded in our Consolidated Statements of Operations as follows:
		Thirteen Weeks Ended						Thirty-Nine Weeks Ended
	Statement of Operations Classification	September 28,			June 29,			September 28,
		2014			2014			2014
	Cost of sales	$	230		$	755		$	985
	Selling, general and administrative	1,831			2,966			4,797
	Restructuring, reorganization and relocation	7,699			2,228			11,259
	Total	$	9,760		$	5,949		$	17,041
Schedule of Restructuring Reserve by Type of Cost	'
	The following table summarizes the charges, expenditures, write-offs and adjustments related to our restructuring, reorganization, relocation and severance accrual (in thousands):
	Thirty-Nine Weeks Ended September 28, 2014	Second Quarter 2014 Realignment			First Quarter 2014 Restructuring			Group Structure Reorganization			Total
	Beginning accrued liability	$	—		$	—		$	50		$	50
	Charged to expense, net	9,928			1,331			—			11,259
	Expenditures	(3,466		)	(1,331		)	(50		)	(4,847		)
	Ending accrued liability	$	6,462		$	—		$	—		$	6,462
	Thirty-Nine Weeks Ended September 29, 2013	Group Structure Organization			Total
	Beginning accrued liability	$	2,692		$	2,692
	Charged to expense, net	1,090			1,090
	Expenditures	(3,466		)	(3,466		)
	Write-offs and adjustments	50			50
	Ending accrued liability	$	366		$	366

Fair_Value_Measurements_of_Ass1

Fair Value Measurements of Assets and Liabilities (Tables)	9 Months Ended
	Sep. 28, 2014
Fair Value Disclosures [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'
	Following are the disclosures related to the fair value of our financial assets and (liabilities) (in thousands):
	September 28, 2014	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. Government-backed securities	$	12,618	$	—		$	—	$	12,618
	Agency bonds	—		51,958			—		51,958
	Commercial paper	—		39,332			—		39,332
	Certificates of deposit	—		17,274			—		17,274
	Municipal bonds	—		31,547			—		31,547
	Corporate bonds	—		9,920			—		9,920
	Trading securities:
	Equity securities – mutual funds	6,945		—			—		6,945
	Derivative contracts, net	—		(4,307		)	—		(4,307		)
	Total	$	19,563	$	145,724		$	—	$	165,287
	December 31, 2013	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. treasury notes	$	10,128	$	—		$	—	$	10,128
	Agency bonds	—		37,961			—		37,961
	Commercial paper	—		39,987			—		39,987
	Certificates of deposit	—		7,786			—		7,786
	Municipal bonds	—		49,319			—		49,319
	Corporate bonds	—		5,001			—		5,001
	Trading securities:
	Equity securities – mutual funds	5,287		—			—		5,287
	Derivative contracts, net	—		(1,113		)	—		(1,113		)
	Total	$	15,415	$	138,941		$	—	$	154,356

Derivative_Instruments_Tables

Derivative Instruments (Tables)	9 Months Ended
	Sep. 28, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Notional Amounts of Outstanding Derivative Positions	'
	The aggregate notional amount of outstanding derivative contracts were as follows (in thousands):
		September 28,				December 31,
		2014				2013
	Cash flow hedges	$	256,000			$	208,446
	Balance sheet hedges	179,835				172,947
	Total outstanding derivative contracts	$	435,835			$	381,393
Schedule of Gain (Loss) Attributable to Foreign Exchange Rate Fluctuations	'
	Changes in fair value of derivatives entered into to mitigate the foreign exchange risks related to these balance sheet items are recorded in other income (expense) together with the transaction gain or loss from the respective balance sheet position as follows (in thousands):
		Thirteen Weeks Ended								Thirty-Nine Weeks Ended
		September 28,				September 29,				September 28,				September 29,
		2014				2013				2014				2013
	Foreign currency loss, inclusive of the impact of derivatives	$	(644	)		$	(638	)		$	(1,597	)		$	(2,164	)
Schedule of Derivatives Instruments, Offsetting in Balance Sheet	'
	Our derivative instruments are subject to master netting arrangements and are presented net in our balance sheet. We do not have any financial collateral related to these netting arrangements. The effect of these netting arrangements on our balance sheet is as follows (in thousands):
		Offsetting of Derivative Assets										Offsetting of Derivative Liabilities
	September 28, 2014	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets				Gross Amounts of Recognized Liabilities			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—			$	4,674		$	(1,428	)	$	3,246
	Foreign exchange contracts not designated as hedging instruments	1,598			(473		)	1,125				4,167			(1,981		)	2,186
	Total	$	1,598		$	(473	)	$	1,125			$	8,841		$	(3,409	)	$	5,432
		Offsetting of Derivative Assets										Offsetting of Derivative Liabilities
	December 31, 2013	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets				Gross Amounts of Recognized Liabilities			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—			$	4,362		$	(3,042	)	$	1,320
	Foreign exchange contracts not designated as hedging instruments	2,171			(698		)	1,473				2,916			(1,650		)	1,266
	Total	$	2,171		$	(698	)	$	1,473			$	7,278		$	(4,692	)	$	2,586
Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations	'
	The effect of derivative instruments was as follows (in thousands):
		Thirteen Weeks Ended								Thirty-Nine Weeks Ended
	Foreign Exchange Contracts in Cash Flow Hedging Relationships	September 28,				September 29,				September 28,				September 29,
		2014				2013				2014				2013
	Amount of gain/(loss):
	Recognized in AOCI (effective portion)	$	(6,757	)		$	(637	)		$	(11,016	)		$	(3,567	)
	Reclassified from AOCI into revenue (effective portion)	1				—				47				—
	Reclassified from AOCI into cost of sales (effective portion)	(2,486		)		120				(4,152		)		(460		)
	Recognized in other, net (ineffective portion and amount excluded from effectiveness testing)	(49		)		—				(58		)		(46		)
	Foreign Exchange Contracts Not in Cash Flow Hedging Relationships
	Amount of gain/(loss):
	Recognized in other, net	$	2,018			$	(491	)		$	5,763			$	3,582

Changes_in_Accumulated_Other_C1

Changes in Accumulated Other Comprehensive Income by Component (Tables)	9 Months Ended
	Sep. 28, 2014
Changes in Accumulated Other Comprehensive Income [Abstract]	'
Schedule of Accumulated Other Comprehensive Income	'
	The following tables illustrate the disclosure of changes in the balances of each component of accumulated other comprehensive income (“AOCI”), as well as details the effect of reclassifications out of AOCI on the line items in the Consolidated Statements of Operations by component (net of tax, in thousands):
		Thirteen Weeks Ended September 28, 2014
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	47,109		$	29		$	(519	)	$	(1,320	)	$	45,299
	Other comprehensive income before reclassifications	(37,778		)	(52		)	45			(5,475		)	(43,260		)
	Amounts reclassified from AOCI to:
	Revenue	—			—			—			(1		)	(1		)
	Cost of goods sold	—			—			—			2,486			2,486
	Other income (expense)	—			—			—			49			49
	Total reclassifications out of AOCI	—			—			—			2,534			2,534
	Net current period other comprehensive income	(37,778		)	(52		)	45			(2,941		)	(40,726		)
	Ending balance	$	9,331		$	(23	)	$	(474	)	$	(4,261	)	$	4,573
		Thirty-Nine Weeks Ended September 28, 2014
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	48,865		$	(11	)	$	(552	)	$	(1,174	)	$	47,128
	Other comprehensive income before reclassifications	(39,534		)	(12		)	78			(7,250		)	(46,718		)
	Amounts reclassified from AOCI to:
	Revenue	—			—			—			(47		)	(47		)
	Cost of goods sold	—			—			—			4,152			4,152
	Other income (expense)	—			—			—			58			58
	Total reclassifications out of AOCI	—			—			—			4,163			4,163
	Net current period other comprehensive income	(39,534		)	(12		)	78			(3,087		)	(42,555		)
	Ending balance	$	9,331		$	(23	)	$	(474	)	$	(4,261	)	$	4,573
		Thirteen Weeks Ended September 29, 2013
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	29,537		$	1		$	(890	)	$	(748	)	$	27,900
	Other comprehensive income before reclassifications	17,126			24			(70		)	1,292			18,372
	Amounts reclassified from AOCI to:
	Cost of goods sold	—			—			—			(120		)	(120		)
	Total reclassifications out of AOCI	—			—			—			(120		)	(120		)
	Net current period other comprehensive income	17,126			24			(70		)	1,172			18,252
	Ending balance	$	46,663		$	25		$	(960	)	$	424		$	46,152
		Thirty-Nine Weeks Ended September 29, 2013
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	38,890		$	4		$	(819	)	$	481		$	38,556
	Other comprehensive income before reclassifications	7,773			21			(141		)	(563		)	7,090
	Amounts reclassified from AOCI to:
	Cost of goods sold	—			—			—			460			460
	Other income (expense)	—			—			—			46			46
	Total reclassifications out of AOCI	—			—			—			506			506
	Net current period other comprehensive income	7,773			21			(141		)	(57		)	7,596
	Ending balance	$	46,663		$	25		$	(960	)	$	424		$	46,152

Organization_and_Basis_of_Pres2

Organization and Basis of Presentation (Details)	Sep. 28, 2014
	country
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Number of countries in which entity operates	50

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Earnings Per Share Reconciliation	'	'	'	'
Basic EPS - net income	$21,647	$28,606	$71,671	$85,400
Basic EPS - shares	41,891	41,750	42,053	39,928
Basic EPS - per share amount	$0.52	$0.69	$1.70	$2.14
Dilutive effect of 2.875% convertible debt - net income	0	0	0	780
Dilutive effect of 2.875% convertible debt - shares	0	0	0	1,727
Dilutive effect of 2.875% convertible debt - per share amount	$0	$0	$0	($0.07)
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - net income	0	0	0	0
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - shares	574	705	571	645
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - per share amount	($0.01)	($0.02)	($0.02)	($0.03)
Diluted EPS - net income	$21,647	$28,606	$71,671	$86,180
Diluted EPS - shares	42,465	42,455	42,624	42,300
Diluted EPS - per share amount	$0.51	$0.67	$1.68	$2.04

Earnings_Per_Share_Antidilutiv

Earnings Per Share - Antidilutive Securities (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from computation of diluted EPS	361	31	246	220
Restricted Stock Units [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share [Line Items]	'	'	'	'
Antidilutive securities excluded from computation of diluted EPS	10	1	8	1

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Details) (Convertible Subordinated Debt [Member])	Sep. 28, 2014	Sep. 29, 2013
Convertible Subordinated Debt [Member]	'	'
Convertible Notes [Line Items]	'	'
Convertible notes, stated interest rate	0.00%	2.88%

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 28, 2014	Sep. 28, 2014	Sep. 28, 2014	8-May-14	7-May-14	8-May-14	7-May-14
		Stock Options [Member]	Restricted Stock Units [Member]	Employee Share Purchase Plan [Member]	Employee Share Purchase Plan [Member]	Stock Incentive Plan [Member]	Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'
Number of shares authorized	'	'	'	4,200,000	3,950,000	11,250,000	11,000,000
Shares available for grant	1,876,336	'	'	'	'	'	'
Shares of common stock reserved for issuance	3,578,885	'	'	'	'	'	'
Total compensation cost not yet recognized	$49.90	'	'	'	'	'	'
Total compensation cost not yet recognized - period for recognition	'1 year 10 months 24 days	'	'	'	'	'	'
Options Outstanding and Exercisable:	'	'	'	'	'	'	'
Options outstanding, number	'	866,618	'	'	'	'	'
Options exercisable, number	'	173,889	'	'	'	'	'
Options outstanding, weighted average exercise price	'	$60.20	'	'	'	'	'
Options exercisable, weighted average exercise price	'	$38.69	'	'	'	'	'
Options outstanding, aggregate intrinsic value	'	17.9	'	'	'	'	'
Options exercisable, aggregate intrinsic value	'	6.9	'	'	'	'	'
Options outstanding, weighted average remaining contractual term (in years)	'	'5 years 1 month 6 days	'	'	'	'	'
Options exercisable, weighted average remaining contractual term (in years)	'	'3 years 7 months 6 days	'	'	'	'	'
Restricted Stock Units Nonvested and Expected to Vest	'	'	'	'	'	'	'
Restricted stock units nonvested, number	'	'	835,933	'	'	'	'
Restricted stock units expected to vest, number	'	'	750,036	'	'	'	'
Restricted stock units nonvested, weighted average grant date per share fair value	'	'	$63.75	'	'	'	'
Restricted stock units expected to vest, weighted average grant date per share fair value	'	'	$62.68	'	'	'	'
Restricted stock units nonvested, aggregate intrinsic value	'	'	65.3	'	'	'	'
Restricted stock units expected to vest, aggregate intrinsic value	'	'	$58.60	'	'	'	'
Restricted stock units nonvested, weighted average remaining term to vest (in years)	'	'	'1 year 3 months 18 days	'	'	'	'
Restricted stock units expected to vest, weighted average remaining term to vest (in years)	'	'	'1 year 2 months 12 days	'	'	'	'

StockBased_Compensation_Alloca

Stock-Based Compensation - Allocation in Income Statement (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	$6,494	$4,604	$17,456	$13,316
Cost of Sales [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	912	571	2,495	1,782
Research and Development Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	762	511	2,092	1,587
Selling, General and Administrative [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	$4,820	$3,522	$12,869	$9,947

Credit_Facilities_and_Restrict2

Credit Facilities and Restricted Cash - Credit Facilities (Details) (USD $)	9 Months Ended
	Sep. 28, 2014
Credit Agreement [Member]	'
Line of Credit Facility [Line Items]	'
Line of credit facility, expiration date	1-Apr-16
Line of credit facility, amount outstanding	$0
Revolving Credit Facility [Member]	'
Line of Credit Facility [Line Items]	'
Line of credit facility, current borrowing capacity	100,000,000
Line of credit facility, additional borrowing capacity	50,000,000
Line of credit facility, maximum borrowing capacity	150,000,000
Credit Agreement Subfacility [Member]	'
Line of Credit Facility [Line Items]	'
Line of credit facility, current borrowing capacity	$50,000,000

Credit_Facilities_and_Restrict3

Credit Facilities and Restricted Cash - Letters of Credit and Restricted Cash (Details) (USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
CREDIT FACILITIES AND RESTRICTED CASH [Abstract]	'	'
Guarantees and letters of credit outstanding	$51,817	'
Current	11,988	18,798
Long-term	38,953	32,718
Total secured by restricted cash	$50,941	'

Inventories_Details

Inventories (Details) (USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Raw materials and assembled parts	$60,219	$61,235
Service inventories, estimated current requirements	13,208	15,197
Work-in-process	83,475	75,883
Finished goods	33,492	29,410
Total current inventories	190,394	181,725
Non-current inventories	$53,845	$62,104

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets - Goodwill (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Goodwill [Roll Forward]	'	'
Goodwill, beginning of period	$136,152	$131,320
Goodwill additions	46,880	3,545
Goodwill adjustments	-5,212	319
Goodwill, end of period	$177,820	$135,184

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets Acquisition information (Details) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014	Sep. 28, 2014	Mar. 30, 2014	Feb. 05, 2014
Business Acquisition [Line Items]	'	'	'	'
Acquisition related goodwill	'	'	'	$46.90
Lithicon AS [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Percentage of voting interests acquired	'	'	'	100.00%
Acquisition purchase price	68	68	'	'
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred	'	0.4	'	'
Business Acquisition, Transaction Costs - Cumulative	0.4	0.4	'	'
Acquisition related transaction costs	'	'	0.3	'
Net tangible assets assumed	'	'	'	7.7
Net intangible assets acquired, fair value	'	'	'	22
Deferred Tax Assets, Goodwill and Intangible Assets	'	'	'	8.1
Revenue	1.9	4.3	'	'
Net loss	-1	-3.1	'	'
Developed technology [Member] | Lithicon AS [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Net intangible assets acquired, weighted average amortization period	'	'10 years	'	'
Net intangible assets acquired, fair value	'	'	'	18.6
Customer relationships [Member] | Lithicon AS [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Net intangible assets acquired, weighted average amortization period	'	'5 years	'	'
Net intangible assets acquired, fair value	'	'	'	2.2
Order or Production Backlog [Member] | Lithicon AS [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Net intangible assets acquired, weighted average amortization period	'	'2 years	'	'
Net intangible assets acquired, fair value	'	'	'	$1.20

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets - Intangible Assets (Details) (USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, accumulated amortization	($27,231)	($19,385)
Total intangible assets included in other long-term assets	59,371	47,197
Patents, trademarks and other [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	25,786	24,327
Finite-lived intangible assets, accumulated amortization	-12,354	-9,296
Total intangible assets included in other long-term assets	13,432	15,031
Customer relationships [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	22,809	21,650
Finite-lived intangible assets, accumulated amortization	-5,428	-3,547
Total intangible assets included in other long-term assets	17,381	18,103
Developed technology [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	35,562	18,161
Finite-lived intangible assets, accumulated amortization	-7,004	-4,098
Total intangible assets included in other long-term assets	28,558	14,063
Note issuance costs [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	2,445	2,445
Finite-lived intangible assets, accumulated amortization	-2,445	-2,445
Total intangible assets included in other long-term assets	$0	$0

Goodwill_and_Other_Intangible_5

Goodwill and Other Intangible Assets - Amortization of Intangibles (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Dec. 31, 2013
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-Lived Intangible Assets, Amortization Expense	$8,638	$6,119	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Remainder of 2014	2,518	'	'
Expected amortization, 2015	10,408	'	'
Expected amortization, 2016	9,467	'	'
Expected amortization, 2017	8,419	'	'
Expected amortization, 2018	7,369	'	'
Thereafter	21,190	'	'
Total intangible assets included in other long-term assets	59,371	'	47,197
Patents, trademarks and other [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-Lived Intangible Assets, Amortization Expense	3,850	2,527	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Remainder of 2014	826	'	'
Expected amortization, 2015	3,643	'	'
Expected amortization, 2016	2,702	'	'
Expected amortization, 2017	2,262	'	'
Expected amortization, 2018	1,661	'	'
Thereafter	2,338	'	'
Total intangible assets included in other long-term assets	13,432	'	15,031
Customer relationships [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-Lived Intangible Assets, Amortization Expense	1,882	1,728	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Remainder of 2014	688	'	'
Expected amortization, 2015	2,749	'	'
Expected amortization, 2016	2,749	'	'
Expected amortization, 2017	2,401	'	'
Expected amortization, 2018	2,321	'	'
Thereafter	6,473	'	'
Total intangible assets included in other long-term assets	17,381	'	18,103
Developed technology [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-Lived Intangible Assets, Amortization Expense	2,906	1,718	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Remainder of 2014	1,004	'	'
Expected amortization, 2015	4,016	'	'
Expected amortization, 2016	4,016	'	'
Expected amortization, 2017	3,756	'	'
Expected amortization, 2018	3,387	'	'
Thereafter	12,379	'	'
Total intangible assets included in other long-term assets	28,558	'	14,063
Note issuance costs [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'7 years	'	'
Finite-Lived Intangible Assets, Amortization Expense	0	146	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Total intangible assets included in other long-term assets	$0	'	$0
Maximum [Member] | Patents, trademarks and other [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'10 years	'	'
Maximum [Member] | Customer relationships [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'10 years	'	'
Maximum [Member] | Developed technology [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'10 years	'	'
Minimum [Member] | Patents, trademarks and other [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'2 years	'	'
Minimum [Member] | Customer relationships [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'5 years	'	'
Minimum [Member] | Developed technology [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'5 years 6 months	'	'

Warranty_Reserves_Details

Warranty Reserves (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013
Product Warranty Reserve Activity [Roll Forward]	'	'
Balance, beginning of period	$12,705	$12,049
Reductions for warranty costs incurred	-10,132	-9,478
Warranties issued	9,826	9,776
Translation and changes in estimates	-271	3
Balance, end of period	$12,128	$12,350

Income_Taxes_Net_Deferred_Tax_

Income Taxes - Net Deferred Tax Assets (Details) (USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred Income Taxes [Abstract]	'	'
Deferred tax assets – current	$9,890	$15,114
Deferred tax assets – non-current	9,156	1,751
Deferred tax liabilities – current	-51	-9
Deferred tax liabilities – non-current	-10,405	-8,931
Net deferred tax assets	8,590	7,925
Valuation allowance	$4,429	$2,723

Income_Taxes_Unrecognized_Tax_

Income Taxes - Unrecognized Tax Benefits and Open Tax Years (Details) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014	Sep. 28, 2014
Income Tax Contingency [Line Items]	'	'
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities	$2.60	$3.10
United States [Member]	'	'
Income Tax Contingency [Line Items]	'	'
Tax years open for examination, by major tax jurisdiction	'	'2011
The Netherlands [Member]	'	'
Income Tax Contingency [Line Items]	'	'
Tax years open for examination, by major tax jurisdiction	'	'2011
Czech Republic [Member]	'	'
Income Tax Contingency [Line Items]	'	'
Tax years open for examination, by major tax jurisdiction	'	'2011

RelatedParty_Activity_Details

Related-Party Activity (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Related Party Transaction [Line Items]	'	'	'	'
Product sales to related parties	$307	$1,169	$2,898	$5,019
Service sales to related parties	351	245	903	613
Total sales to related parties	658	1,414	3,801	5,632
Purchases from related parties	436	66	1,804	289
Applied Materials [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Product sales to related parties	230	1,039	2,572	4,630
Service sales to related parties	256	220	611	550
Lattice Semiconductor [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Product sales to related parties	0	0	0	4
Service sales to related parties	3	3	9	9
Cascade Microtech [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Service sales to related parties	9	8	25	24
Oregon Health and Science University [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Product sales to related parties	77	130	326	385
Service sales to related parties	83	14	258	30
Purchases from related parties	41	39	119	214
TMC BV [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Purchases from related parties	$395	$27	$1,685	$75

RelatedParty_Activity_Schedule

Related-Party Activity - Schedule of Amounts Due From (To) Related Parties (Details) (USD $)	Sep. 28, 2014
In Thousands, unless otherwise specified
Related Party Transaction [Line Items]	'
Due from (to) related party	$370
Applied Materials [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	433
Cascade Microtech [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	8
Oregon Health and Science University [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	4
TMC BV [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	($75)

Commitments_and_Contingencies_

Commitments and Contingencies - Purchase Obligations (Details) (Inventories [Member], USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014
Inventories [Member]	'
Unrecorded Unconditional Purchase Obligation [Line Items]	'
Non-cancelable purchase orders	$80
Purchase commitment, maximum expiration date	'second quarter of 2016

Segment_Information_Sales_to_E

Segment Information - Sales to External Customers and Gross Profit (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Segment Reporting Information [Line Items]	'	'	'	'
Sales to external customers	$227,756	$218,496	$690,976	$662,163
Gross profit	108,581	104,745	324,756	314,193
Industry [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Sales to external customers	107,058	103,627	340,722	306,393
Gross profit	55,101	56,216	175,321	160,517
Science [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Sales to external customers	120,698	114,869	350,254	355,770
Gross profit	$53,480	$48,529	$149,435	$153,676

Segment_Information_Goodwill_a

Segment Information - Goodwill and Total Assets (Details) (USD $)	Sep. 28, 2014	Dec. 31, 2013	Sep. 29, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Segment Reporting Information [Line Items]	'	'	'	'
Goodwill	$177,820	$136,152	$135,184	$131,320
Total Assets	1,439,516	1,426,084	'	'
Industry [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Goodwill	97,598	51,532	'	'
Total Assets	403,355	297,987	'	'
Science [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Goodwill	80,222	84,620	'	'
Total Assets	346,578	365,571	'	'
Corporate Eliminations [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Total Assets	$689,583	$762,526	'	'

Restructuring_Reorganization_R2

Restructuring, Reorganization, Relocation and Severance (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 28, 2014

Sep. 29, 2013

Sep. 28, 2014

Sep. 29, 2013

Sep. 28, 2014

Sep. 28, 2014

Sep. 29, 2013

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Mar. 30, 2014

Sep. 28, 2014

Dec. 31, 2012

Dec. 31, 2013

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Sep. 28, 2014

Jun. 29, 2014

Sep. 28, 2014

Second Quarter 2014 Restructuring Plan [Member]

Group Structure Reorganization [Member]

Group Structure Reorganization [Member]

First Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

First Quarter 2014 Restructuring Plan [Member]

First Quarter 2014 Restructuring Plan [Member]

Group Structure Reorganization [Member]

Group Structure Reorganization [Member]

Realignment Costs [Member]

Realignment Costs [Member]

Realignment Costs [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

General and Administrative Expense [Member]

General and Administrative Expense [Member]

General and Administrative Expense [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Restructuring Charges [Member]

Restructuring Charges [Member]

Restructuring Charges [Member]

Realignment Costs [Member]

Acquisition Related Earn Out [Member]

Acquisition Related Earn Out [Member]

Acquisition Related Earn Out [Member]

Inventory Write-offs [Member]

Inventory Write-offs [Member]

Inventory Write-offs [Member]

Impairment and Other Asset Write-off [Member]

Impairment and Other Asset Write-off [Member]

Impairment and Other Asset Write-off [Member]

Restructuring Charges [Member]

Restructuring Charges [Member]

Restructuring Charges [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Second Quarter 2014 Restructuring Plan [Member]

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Actual savings anticipated by restructuring activity

'

'

'

'

'

'

'

'

$10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring, reorganization, relocation and severance

7,699,000

0

11,259,000

1,090,000

9,928,000

0

1,090,000

1,331,000

'

'

0

2,500,000

2,500,000

230,000

755,000

985,000

1,831,000

466,000

2,297,000

7,699,000

2,228,000

11,259,000

1,300,000

'

2,900,000

1,100,000

9,760,000

5,949,000

17,041,000

9,760,000

5,949,000

17,041,000

1,831,000

2,966,000

4,797,000

230,000

755,000

985,000

7,699,000

2,228,000

11,259,000

Restructuring Reserve [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning accrued liability

'

'

50,000

2,692,000

0

50,000

2,692,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring, reorganization, relocation and severance

7,699,000

0

11,259,000

1,090,000

9,928,000

0

1,090,000

1,331,000

'

'

0

2,500,000

2,500,000

230,000

755,000

985,000

1,831,000

466,000

2,297,000

7,699,000

2,228,000

11,259,000

1,300,000

'

2,900,000

1,100,000

9,760,000

5,949,000

17,041,000

9,760,000

5,949,000

17,041,000

1,831,000

2,966,000

4,797,000

230,000

755,000

985,000

7,699,000

2,228,000

11,259,000

Expenditures

'

'

-4,847,000

-3,466,000

-3,466,000

-50,000

-3,466,000

-1,331,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Write-offs and adjustments

'

'

'

50,000

'

'

50,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ending accrued liability

6,462,000

366,000

6,462,000

366,000

6,462,000

0

366,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected total cost of restructuring plan

'

'

'

'

'

'

'

'

$26,000,000

$24,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$4,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair_Value_of_Assets_and_Liabi

Fair Value of Assets and Liabilities - Securities (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	$6,945	$5,287
Derivative contracts, net	0	0
Assets, fair value	19,563	15,415
Fair Value, Inputs, Level 1 [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	12,618	10,128
Fair Value, Inputs, Level 1 [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	0	0
Derivative contracts, net	-4,307	-1,113
Assets, fair value	145,724	138,941
Fair Value, Inputs, Level 2 [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 2 [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	51,958	37,961
Fair Value, Inputs, Level 2 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	39,332	39,987
Fair Value, Inputs, Level 2 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	17,274	7,786
Fair Value, Inputs, Level 2 [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	31,547	49,319
Fair Value, Inputs, Level 2 [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	9,920	5,001
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	0	0
Derivative contracts, net	0	0
Assets, fair value	0	0
Fair Value, Inputs, Level 3 [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Estimate of Fair Value Measurement [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	6,945	5,287
Derivative contracts, net	-4,307	-1,113
Assets, fair value	165,287	154,356
Estimate of Fair Value Measurement [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	12,618	10,128
Estimate of Fair Value Measurement [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	51,958	37,961
Estimate of Fair Value Measurement [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	39,332	39,987
Estimate of Fair Value Measurement [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	17,274	7,786
Estimate of Fair Value Measurement [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	31,547	49,319
Estimate of Fair Value Measurement [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	$9,920	$5,001

Derivative_Instruments_Details

Derivative Instruments (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013	Dec. 31, 2013
Notional Amount of Derivatives, Total [Abstract]	'	'	'	'	'
Total outstanding derivative contracts	$435,835	'	$435,835	'	$381,393
Foreign currency loss, inclusive of the impact of derivatives	-644	-638	-1,597	-2,164	'
Cash Flow Hedges [Member]	'	'	'	'	'
Notional Amount of Derivatives, Total [Abstract]	'	'	'	'	'
Total outstanding derivative contracts	256,000	'	256,000	'	208,446
Balance Sheet Hedges [Member]	'	'	'	'	'
Notional Amount of Derivatives, Total [Abstract]	'	'	'	'	'
Total outstanding derivative contracts	$179,835	'	$179,835	'	$172,947

Derivative_Instruments_Balance

Derivative Instruments - Balance Sheet Location (Details) (Foreign Exchange Contract [Member], USD $)	Sep. 28, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other Current Assets [Member]	'	'
Offsetting Derivative Assets [Abstract]	'	'
Gross amounts of recognized assets	$1,598	$2,171
Gross amounts offset in the balance sheet	-473	-698
Net amounts presented in other current assets	1,125	1,473
Other Current Liabilities [Member]	'	'
Offsetting Derivative Liabilities [Abstract]	'	'
Gross amounts of recognized liabilities	8,841	7,278
Gross amounts offset in the balance sheet	-3,409	-4,692
Net amounts presented in other current liabilities	5,432	2,586
Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Offsetting Derivative Assets [Abstract]	'	'
Gross amounts of recognized assets	0	0
Gross amounts offset in the balance sheet	0	0
Net amounts presented in other current assets	0	0
Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Offsetting Derivative Liabilities [Abstract]	'	'
Gross amounts of recognized liabilities	4,674	4,362
Gross amounts offset in the balance sheet	-1,428	-3,042
Net amounts presented in other current liabilities	3,246	1,320
Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Offsetting Derivative Assets [Abstract]	'	'
Gross amounts of recognized assets	1,598	2,171
Gross amounts offset in the balance sheet	-473	-698
Net amounts presented in other current assets	1,125	1,473
Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Offsetting Derivative Liabilities [Abstract]	'	'
Gross amounts of recognized liabilities	4,167	2,916
Gross amounts offset in the balance sheet	-1,981	-1,650
Net amounts presented in other current liabilities	$2,186	$1,266

Derivative_Instruments_Effect_

Derivative Instruments - Effect on Income Statement (Details) (Foreign Exchange Contract [Member], USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Other Comprehensive Income (Loss) [Member] | Cash Flow Hedges [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Recognized in AOCI (effective portion)	($6,757)	($637)	($11,016)	($3,567)
Sales Revenue, Net [Member] | Cash Flow Hedges [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Reclassified from AOCI into income (effective portion)	1	0	47	0
Cost of Sales [Member] | Cash Flow Hedges [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Reclassified from AOCI into income (effective portion)	-2,486	120	-4,152	-460
Other Income Expense Net [Member] | Not Designated as Hedging Instrument [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Recognized in other, net	2,018	-491	5,763	3,582
Other Income Expense Net [Member] | Cash Flow Hedges [Member]	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Recognized in other, net (ineffective portion and amount excluded from effectiveness testing)	($49)	$0	($58)	($46)

Changes_in_Accumulated_Other_C2

Changes in Accumulated Other Comprehensive Income by Component (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Sep. 29, 2013
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	$45,299	$27,900	$47,128	$38,556
Other comprehensive income before reclassifications	-43,260	18,372	-46,718	7,090
Cost of goods sold	119,175	113,751	366,220	347,970
Other income (expense)	-831	-661	-1,907	-3,618
Net current period other comprehensive income	-40,726	18,252	-42,555	7,596
Ending balance	4,573	46,152	4,573	46,152
Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Revenues	-1	'	-47	'
Cost of goods sold	2,486	-120	4,152	460
Other income (expense)	49	'	58	46
Total reclassification out of AOCI	2,534	-120	4,163	506
Accumulated Translation Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	47,109	29,537	48,865	38,890
Other comprehensive income before reclassifications	-37,778	17,126	-39,534	7,773
Net current period other comprehensive income	-37,778	17,126	-39,534	7,773
Ending balance	9,331	46,663	9,331	46,663
Accumulated Translation Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Revenues	0	'	0	'
Cost of goods sold	0	0	0	0
Other income (expense)	0	'	0	0
Total reclassification out of AOCI	0	0	0	0
Accumulated Net Unrealized Investment Gain (Loss) [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	29	1	-11	4
Other comprehensive income before reclassifications	-52	24	-12	21
Net current period other comprehensive income	-52	24	-12	21
Ending balance	-23	25	-23	25
Accumulated Net Unrealized Investment Gain (Loss) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Revenues	0	'	0	'
Cost of goods sold	0	0	0	0
Other income (expense)	0	'	0	0
Total reclassification out of AOCI	0	0	0	0
Accumulated Defined Benefit Plans Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	-519	-890	-552	-819
Other comprehensive income before reclassifications	45	-70	78	-141
Net current period other comprehensive income	45	-70	78	-141
Ending balance	-474	-960	-474	-960
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Revenues	0	'	0	'
Cost of goods sold	0	0	0	0
Other income (expense)	0	'	0	0
Total reclassification out of AOCI	0	0	0	0
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Beginning balance	-1,320	-748	-1,174	481
Other comprehensive income before reclassifications	-5,475	1,292	-7,250	-563
Net current period other comprehensive income	-2,941	1,172	-3,087	-57
Ending balance	-4,261	424	-4,261	424
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'	'	'
Accumulated Other Comprehensive Income, Net of Tax [Roll Forward]	'	'	'	'
Revenues	-1	'	-47	'
Cost of goods sold	2,486	-120	4,152	460
Other income (expense)	49	'	58	46
Total reclassification out of AOCI	$2,534	($120)	$4,163	$506

Factoring_of_Accounts_Receivab1

Factoring of Accounts Receivable (Details) (USD $)	3 Months Ended		9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Sep. 28, 2014	Sep. 29, 2013	Sep. 28, 2014	Dec. 31, 2013
Factoring of Accounts Receivable [Abstract]	'	'	'	'
Accounts receivable sold without recourse	$3	$3.20	$7	$8.10